Liquid Crystal Biosensor for RNA Virus Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for respiratory viral infections, such as those caused by SARS-CoV-2, are inadequate due to their lack of sensitivity, specificity, and the need for laboratory-based equipment, making them unsuitable for rapid point-of-care detection and use in low-resource settings.
Innovation Solution
The development of biosensors using liquid crystals that detect RNA viruses by reorienting in response to target nucleic acid analytes, allowing for visual detection of RNA sequences like SARS-CoV-2 with high sensitivity and selectivity, and the creation of a smartphone-based application for result interpretation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional diagnostic methods (viral culture, EIA, DFA, RT-PCR) are used, then sensitivity and specificity can be achieved, but the methods require laboratory-based equipment and are not suitable for point-of-care detection
Solution Approach 1:
The patent extracts the detection function from complex laboratory equipment and implements it using a simple liquid crystal-based optical system that can be viewed with the naked eye or basic microscopy, eliminating the need for sophisticated laboratory instruments while maintaining detection sensitivity
Solution Approach 2:
The patent replaces mechanical/chemical diagnostic systems (ELISA, PCR, DFA) with an optical system based on liquid crystal reorientation, which provides rapid visual detection without requiring complex mechanical or chemical processing equipment
2Measurement precision
If viral culture is used as the gold standard, then sensitivity and specificity are achieved, but the method requires 3-10 days to provide results
Solution Approach 1:
The patent prepares the liquid crystal sensor with nucleic acid probes in advance, so that when a clinical sample is introduced, hybridization can occur immediately and the result is visualized rapidly through liquid crystal reorientation, eliminating the extended incubation time required by viral culture
Solution Approach 2:
The patent utilizes the phase transition properties of liquid crystals, which change their optical state in response to molecular hybridization events, enabling rapid detection without requiring the prolonged incubation periods needed for viral culture to produce visible cytopathic effects
3Loss of time
If EIA and optical immunoassay are used for rapid results, then detection time is reduced to 30 minutes, but the assays lack adequate sensitivity and specificity
Solution Approach 1:
The patent creates a composite system combining liquid crystals with specifically designed nucleic acid probes that have high affinity and specificity for target viral sequences, achieving both rapid detection and high sensitivity through the synergistic combination of these materials
Solution Approach 2:
The patent utilizes the optical birefringence properties of liquid crystals that produce visible color/pattern changes when they reorient in response to target binding, providing a visual readout that is both rapid and highly sensitive without requiring complex instrumentation
4Measurement precision
If DFA is used to achieve sensitivity comparable to viral culture, then detection accuracy is improved, but the method requires high-quality equipment, skilled microscopist, and is labor-intensive
Solution Approach 1:
The patent designs a system where the liquid crystal sensor automatically indicates positive results through spontaneous optical changes when target nucleic acid is detected, eliminating the need for skilled microscopists to interpret complex microscopic images and reducing labor intensity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, reliable, and cost-effective detection of RNA viruses at the point of care, with ultrahigh sensitivity and selectivity, overcoming the limitations of existing methods by providing a simple, portable, and user-friendly diagnostic tool.
Implementation Method 1
allowing the target nucleic acid analyte to hybridize to the nucleic acid probe, thereby reorienting the liquid crystal
Implementation Method 2
allowing the target nucleic acid analyte to hybridize to the nucleic acid probe
Implementation Method 3
the detection region of the biosensor comprises a nucleic acid probe-cationic surfactant layer present at the interface of a liquid crystal and a polar solvent
Data Source
AI summary
Described herein are biosensors and methods that employ liquid crystals to detect and/or identify RNA viruses.